Glenmark Pharmaceuticals Limited

₹1,985.6+0.54%Dec 15, 3:45 PM IST

GLENMARK•Health Technology•Pharmaceuticals: Major

Current Price

₹1,985.6+0.54%

Dec 15, 3:45 PM IST

Market Cap₹55,707.85 Cr

Business Overview

Glenmark Pharmaceuticals Ltd. operates through 5 main business divisions including Respiratory, Dermatology, Oncology, Other Therapies, Ichnos Glenmark Innovation (IGI).

Business Hierarchy Structure for Glenmark Pharmaceuticals Ltd.

Glenmark Pharmaceuticals Ltd.
- Respiratory
  - India
    - Airz™
    - Nebzmart®
    - Vilor-F™
    - Ascoril®
    - Alex®-BL
    - Indactiv®-G
    - Vilor-F™ pMDI
    - Nindanib
    - ASCORIL®-LS
    - ASCORIL® +
    - ASCORIL®-D
  - North America
    - Levocetirizine Dihydrochloride
    - gFlovent 44mcg pMDI
    - RYALTRIS®
  - Europe
    - Pirfenidone film-coated tablets
    - RYALTRIS®
    - SALMEX® / ASTHMEX®
  - Rest of the World (RoW)
    - Russia
      - ASCORIL® LS
      - Fenismart® Oral Drops
      - Phelisans® Ear Drops
      - Fenismart® Gel
    - Latin America
      - Salmeterol + Fluticasone MDI
      - Infasurf
      - Dirnelid AZ®
    - Asia-Pacific (APAC)
      - Glencet® M
      - QuazziISO®
      - Pecof Dry®
    - MEA
      - RYALTRIS® (South Africa, Kenya, Saudi Arabia, UAE)
- Dermatology
  - Anti-fungal Segment
    - Candid-B®
    - Scalpe™+
    - Canditral® SB
    - Candid®
    - Keto Plus®
    - Klenzit®
    - Candid® Powder
    - Candidox®
    - Lulican®
  - Clinical Dermatology
    - Momate®
    - Tobraza® 2% Ointment
    - Episoft® AC SPF 50
    - La Shield® Sports Sunscreen Gel SPT 50+
  - Consumer Care Brands
    - Episoft®
    - Elovera®
    - La Shield®
    - Bontress® Pro Plus Serum
    - Bontress® Plus Shampoo
    - Hair4U® Boost
    - Cysteo™
  - Partnership with Pfizer
    - JABRYUS® (Abrocitinib)
  - North America
    - Tacrolimus ointment 0.03%
    - Clindamycin Hydrochloride capsules
  - Europe & South Africa
    - WINLEVI® (Clascoterone Cream 1%)
- Oncology
  - Supportive Cancer Care
    - Akynzeo® I.V.
    - Akynzeo® capsules
    - Aprecap®
  - Prostate Cancer
    - Abiraterone Glenmark
    - Reglid®
    - Tripty®
  - Breast Cancer
    - Aplet® (Apalutamide)
  - Lung Cancer
    - Envafolimab (SubQ next gen PDL-1)
  - Hematological Malignancies
    - Tislelizumab
    - Zanubrutinib
  - India
    - Akynzeo® I.V.
    - Aplet® (Apalutamide)
    - Olparib®
    - Reglid®
    - Tripty®
    - Eltrog™
  - Europe
    - Abiraterone Glenmark
    - Capecitabine Glenmark
    - Farpenta®
    - SALMETEROL/FLUTICASONE MDI
    - CEFIXIME TAB 400MG
    - Pirfenidon Glenmark
    - RYALTRIS® 240 MD SK
    - DULOXETINE CAP GR 90MG
    - METFORMIN TAB 1000mg
  - LatAm
    - Nintedanib
    - Gemcitabine
    - Abiraterone
  - APAC
    - Envafolimab
- Other Therapies
  - Diabetes
    - Remogliflozin (Remo®)
    - Teneligliptin (Zita Plus®, Ziten®)
    - Sitagliptin (Sitazit®)
    - Lobeglitazone Sulfate and Glimepiride (LOBG®-G1)
    - Zita® DM
    - Lirafit™ (Liraglutide biosimilar)
  - Cardio-vascular
    - Telma®
    - Telma®-H
    - Telma®-AM
    - Telma®-CT
    - Eptus®
    - SACU-V®
    - Telma® BS
  - Women's Health
    - ALYACEN® 1/35
    - BRIELLYN®
    - CHARLOTTE® 24 Fe
    - HAILEY™
    - MARLISSA®
    - VIORELE®
    - Estradiol Vaginal Inserts USP
    - Norethindrone Acetate and Ethinyl Estradiol Capsules
    - Ferrous Fumarate Capsules (Taytulla®)
- Ichnos Glenmark Innovation (IGI)
  - Oncology Pipeline
    - ISB 2001 (TREAT™ trispecific antibody)
    - ISB 1442 (BEAT® biparatopic bispecific antibody)
    - GRC 65327 (Cbl-b Inhibitor)
  - Autoimmune Diseases Pipeline
    - ISB 880 (IL-1RAP Antagonist Monoclonal Antibody)
    - ISB 830 (Telazorlimab OX40 Antagonist Antibody)